logo
logo

Targed Biopharmaceuticals Picks Up Series A

Targed Biopharmaceuticals Picks Up Series A

02/22/22, 3:46 PM
Round Type
series a
TargED Biopharmaceuticals, a developer of treatments for thrombotic diseases, has raised 39 million euros in Series A financing.

Company Info

Company
Targ Ed Biopharmaceuticals